Cagent Vascular vs XCath

Cagent Vascular vs XCath, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cagent Vascular is on 42/100 and XCath on 54/100.

Cagent Vascular logo
Cagent VascularDeveloping innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.
Try Cagent Vascular
XCath logo
XCathPioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.
Try XCath

Where each one leads

Cagent Vascular

  • domain rating: 25/100 against 12/100

XCath

  • our overall score: 54/100 against 42/100
  • agent readiness: 41/100 against 21/100
  • funding raised: $54.0M against $41.0M

At a glance

MeasureCagent VascularXCath
What it isDeveloping innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.
CategoryMedical Devices, Healthcare, BiotechnologyMedical Devices, Robotics, Healthcare, Biotechnology
Sells toBusiness modelB2BB2B
OfferingHardwareHardware
Founded20152017
HeadquartersWayne, USAHouston, United States
StatusActiveActive

Size, funding and growth

MeasureCagent VascularXCath
EmployeesNot published31
Total funding$41.0M$54.0M
Latest roundSeries DSeries C

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCagent VascularXCath
StartupHub scoreOur 0-100 rating42/10054/100
Traction38/10054/100
TeamNot published30/100
Search visibility10/1009/100
Quality58/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (41/100)
Domain ratingLink authority, 0-10025/10012/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCagent VascularXCath
CDNCloudflareFastly
CMSSquarespaceNot detected
FrameworksNot detectedJquery, Tailwind CSS, Bootstrap
AnalyticsGoogle Analytics 4, Google Tag ManagerNot detected

Cagent Vascular vs XCath: common questions

Which is better, Cagent Vascular or XCath?

On our 0-100 score XCath rates higher (54/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Cagent Vascular and XCath compare on the numbers?

Cagent Vascular leads on domain rating (25/100 against 12/100). XCath leads on our overall score (54/100 against 42/100), agent readiness (41/100 against 21/100), funding raised ($54.0M against $41.0M).

Read the full Cagent Vascular review and pricing or the XCath review and pricing. You can also browse other Cagent Vascular alternatives we track.